# ORBACTIV
> **NDA206334** · New Drug Application · Sponsor: MELINTA THERAP · Approved 2014-08-06
## Drug
- **FDA Application Number:** NDA206334
- **Application type:** New Drug Application
- **Brand name:** ORBACTIV
- **Generic name:** ORITAVANCIN
- **Active ingredients:** ORITAVANCIN DIPHOSPHATE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** MELINTA THERAP
- **Manufacturer:** Melinta Therapeutics, LLC
- **First approval:** 2014-08-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206334)
---
*AI Analytics · CC0 1.0*